*ST Changsheng, who was deeply mired in the market due to the vaccination of the vaccine, is one step closer to the market.
End of the 30-day delisting risk warning transaction, March 6, 2019 *ST ChangshengSuspensionWaiting for the Shenzhen Stock Exchange to make a decision on whether to suspend the listing. On the 8th day of suspension, on the evening of March 13, *ST Changsheng releasedannouncementIt said that the company received the decision on the suspension of listing of Changsheng Biotechnology Co., Ltd. issued by the Shenzhen Stock Exchange on the same day. The company's stock will be suspended from March 15, 2019.
According to relevant regulations, *ST Changsheng will be suspended for 6 months. After the suspension of listing, the Shenzhen Stock Exchange will decide whether to terminate the listing of the company's stock. If it is terminated, the company's stock trading will enter the delisting period. For 30 trading days. For investors who still hold *ST longevity after the delisting risk warning transaction ends, investors will have 30 trading days after the suspension of listing.
On July 15, 2018, a notice issued by the State Drug Administration's official website on "Changchun Changsheng Biotechnology Co., Ltd. illegally produced freeze-dried human rabies vaccine" gave the longevity (original stock abbreviation) vaccine fraud incident exposure.
Three months later, Changchun Changsheng, the company's main subsidiary, produced vaccines for violations of laws and regulations, and was given administrative punishments by the drug regulatory authorities for revoking drug production licenses and penalizing 9.1 billion yuan. Due to the bad circumstances of the above-mentioned illegal acts, which seriously damaged the national interests and the public interests of the society, and touched on the serious illegal delisting of the law as stipulated by the Shenzhen Stock Exchange, the Shenzhen Stock Exchange initiated a mandatory delisting mechanism for the company.
After the exposure of the *ST longevity vaccination in the market, the company's share price continued to fall. Statistics show that from July 16, 2018 to March 5, 2019, *ST Changsheng's share price fell by nearly 94% in 233 trading days, and the market value evaporated by 22.4 billion yuan. As of March 5, 2019, *ST Changsheng closed at 1.51 yuan / share.
Talking about the fact that *ST Changsheng was forced to withdraw from the market due to major violations of the law, Song Qinghui, chief economist of Qinghui Think Tank, said that the Shenzhen Stock Exchange imposed a mandatory delisting on *ST Changsheng, demonstrating the determination of the regulatory authorities to control the stock market. The falsification of the long-lived biological vaccine is a major illegal event, and its nature is very bad. The relevant personnel involved have been arrested and forced to withdraw from the market as early as expected.
Song Qinghui said: "It is almost impossible for Changsheng Bio to return to A shares after being forced to withdraw from the market due to major illegal acts." In his view, the Shanghai and Shenzhen Stock Exchanges are retiring new rules. The two types of compulsory delisting of major illegal securities and major public safety violations were clearly defined, and companies that were forced to withdraw from the market due to major illegal acts were basically completely sealed down.
(Article source: Securities Daily)